Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 4 | |
Outperform | 8 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 12 analysts offering 12 month price targets for Nurix Therapeutics Inc have a median target of 30.00, with a high estimate of 36.00 and a low estimate of 15.00. The median estimate represents a 19.71% increase from the last price of 25.06.
High | 43.7% | 36.00 |
Med | 19.7% | 30.00 |
Low | -40.1% | 15.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 10, 2024.
Average growth rate | -14.12% |
Average growth rate | -2.08% |
More ▼
Revenue history & estimates in USD
Average growth rate | -18.85% |
Average growth rate | +65.36% |
More ▼